This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrowReprints and Permissions
Right arrow Copyright Information
Right arrow Books from ASM Press
Right arrow MicrobeWorld
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Verduin, C. M.
Right arrow Articles by van Belkum, A.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Verduin, C. M.
Right arrow Articles by van Belkum, A.

 Previous Article  |  Next Article 

Clinical Microbiology Reviews, January 2002, p. 125-144, Vol. 15, No. 1
0893-8512/02/$04.00+0     DOI: 10.1128/CMR.15.1.125-144.2002
Copyright © 2002, American Society for Microbiology. All Rights Reserved.

Moraxella catarrhalis: from Emerging to Established Pathogen

Cees M. Verduin,1* Cees Hol,2 André Fleer,3 Hans van Dijk,3 and Alex van Belkum1

Department of Medical Microbiology & Infectious Diseases, Erasmus University Medical Center Rotterdam EMCR, 3015 GD Rotterdam,1 Department of Medical Microbiology, Eemland Hospital, 3800 BM Amersfoort,2 Eijkman-Winkler Institute for Microbiology, Infectious Diseases and Inflammation, Utrecht University Medical Center, University Hospital G04.614, 3508 GA Utrecht, The Netherlands3

Moraxella catarrhalis (formerly known as Branhamella catarrhalis) has emerged as a significant bacterial pathogen of humans over the past two decades. During this period, microbiological and molecular diagnostic techniques have been developed and improved for M. catarrhalis, allowing the adequate determination and taxonomic positioning of this pathogen. Over the same period, studies have revealed its involvement in respiratory (e.g., sinusitis, otitis media, bronchitis, and pneumonia) and ocular infections in children and in laryngitis, bronchitis, and pneumonia in adults. The development of (molecular) epidemiological tools has enabled the national and international distribution of M. catarrhalis strains to be established, and has allowed the monitoring of nosocomial infections and the dynamics of carriage. Indeed, such monitoring has revealed an increasing number of B-lactamase-positive M. catarrhalis isolates (now well above 90%), underscoring the pathogenic potential of this organism. Although a number of putative M. catarrhalis virulence factors have been identified and described in detail, their relationship to actual bacterial adhesion, invasion, complement resistance, etc. (and ultimately their role in infection and immunity), has been established in a only few cases. In the past 10 years, various animal models for the study of M. catarrhalis pathogenicity have been described, although not all of these models are equally suitable for the study of human infection. Techniques involving the molecular manipulation of M. catarrhalis genes and antigens are also advancing our knowledge of the host response to and pathogenesis of this bacterial species in humans, as well as providing insights into possible vaccine candidates. This review aims to outline our current knowledge of M. catarrhalis, an organism that has evolved from an emerging to a well-established human pathogen.


* Corresponding author. Mailing address: Department of Medical Microbiology & Infectious Diseases, Erasmus University Medical Center Rotterdam EMCR, Dr. Molewaterplein 40, 3015 GD Rotterdam, The Netherlands. Phone: 31-10-4633510. Fax: 31-10-4633875. E-mail: verduin{at}bacl.azr.nl.


Clinical Microbiology Reviews, January 2002, p. 125-144, Vol. 15, No. 1
0893-8512/02/$04.00+0     DOI: 10.1128/CMR.15.1.125-144.2002
Copyright © 2002, American Society for Microbiology. All Rights Reserved.




This article has been cited by other articles:

  • Bell, J. M., Turnidge, J. D., Jones, R. N. (2009). Development of a Disk Diffusion Method for Testing Moraxella catarrhalis Susceptibility Using Clinical and Laboratory Standards Institute Methods: a SENTRY Antimicrobial Surveillance Program Report. J. Clin. Microbiol. 47: 2187-2193 [Abstract] [Full Text]  
  • Vela, A. I., Arroyo, E., Aragon, V., Sanchez-Porro, C., Latre, M. V., Cerda-Cuellar, M., Ventosa, A., Dominguez, L., Fernandez-Garayzabal, J. F. (2009). Moraxella pluranimalium sp. nov., isolated from animal specimens. Int. J. Syst. Evol. Microbiol. 59: 671-674 [Abstract] [Full Text]  
  • Easton, D. M., Maier, E., Benz, R., Foxwell, A. R., Cripps, A. W., Kyd, J. M. (2008). Moraxella catarrhalis M35 Is a General Porin That Is Important for Growth under Nutrient-Limiting Conditions and in the Nasopharynges of Mice. J. Bacteriol. 190: 7994-8002 [Abstract] [Full Text]  
  • Wang, W., Richardson, A. R., Martens-Habbena, W., Stahl, D. A., Fang, F. C., Hansen, E. J. (2008). Identification of a Repressor of a Truncated Denitrification Pathway in Moraxella catarrhalis. J. Bacteriol. 190: 7762-7772 [Abstract] [Full Text]  
  • Brooks, M. J., Sedillo, J. L., Wagner, N., Laurence, C. A., Wang, W., Attia, A. S., Hansen, E. J., Gray-Owen, S. D. (2008). Modular Arrangement of Allelic Variants Explains the Divergence in Moraxella catarrhalis UspA Protein Function. Infect. Immun. 76: 5330-5340 [Abstract] [Full Text]  
  • Yu, S., Xie, H., Datta, A., Naidu, N., Gu, X.-X. (2008). Galactose Residues on the Lipooligosaccharide of Moraxella catarrhalis 26404 Form the Epitope Recognized by the Bactericidal Antiserum from Conjugate Vaccination. Infect. Immun. 76: 4251-4258 [Abstract] [Full Text]  
  • Attia, A. S., Sedillo, J. L., Wang, W., Liu, W., Brautigam, C. A., Winkler, W., Hansen, E. J. (2008). Moraxella catarrhalis Expresses an Unusual Hfq Protein. Infect. Immun. 76: 2520-2530 [Abstract] [Full Text]  
  • Schwingel, J. M, Michael, F. S., Cox, A. D, Masoud, H., Richards, J. C, Campagnari, A. A (2008). A unique glycosyltransferase involved in the initial assembly of Moraxella catarrhalis lipooligosaccharides. Glycobiology 18: 447-455 [Abstract] [Full Text]  
  • Jendholm, J., Samuelsson, M., Cardell, L.-O., Forsgren, A., Riesbeck, K. (2008). Moraxella catarrhalis-dependent tonsillar B cell activation does not lead to apoptosis but to vigorous proliferation resulting in nonspecific IgM production. J. Leukoc. Biol. 83: 1370-1378 [Abstract] [Full Text]  
  • Manolov, T., Tan, T. T., Forsgren, A., Riesbeck, K. (2008). Moraxella-Dependent {alpha}1-Antichymotrypsin Neutralization: A Unique Virulence Mechanism. Am. J. Respir. Cell Mol. Bio. 38: 609-617 [Abstract] [Full Text]  
  • Slevogt, H., Maqami, L., Vardarowa, K., Beermann, W., Hocke, A. C., Eitel, J., Schmeck, B., Weimann, A., Opitz, B., Hippenstiel, S., Suttorp, N., N'Guessan, P. D. (2008). Differential regulation of Moraxella catarrhalis-induced interleukin-8 response by protein kinase C isoforms. Eur Respir J 31: 725-735 [Abstract] [Full Text]  
  • Luke, N. R., Jurcisek, J. A., Bakaletz, L. O., Campagnari, A. A. (2007). Contribution of Moraxella catarrhalis Type IV Pili to Nasopharyngeal Colonization and Biofilm Formation. Infect. Immun. 75: 5559-5564 [Abstract] [Full Text]  
  • Wirth, T., Morelli, G., Kusecek, B., van Belkum, A., van der Schee, C., Meyer, A., Achtman, M. (2007). The rise and spread of a new pathogen: Seroresistant Moraxella catarrhalis. Genome Res 17: 1647-1656 [Abstract] [Full Text]  
  • Wang, W., Reitzer, L., Rasko, D. A., Pearson, M. M., Blick, R. J., Laurence, C., Hansen, E. J. (2007). Metabolic Analysis of Moraxella catarrhalis and the Effect of Selected In Vitro Growth Conditions on Global Gene Expression. Infect. Immun. 75: 4959-4971 [Abstract] [Full Text]  
  • Yu, S., Gu, X.-X. (2007). Biological and Immunological Characteristics of Lipooligosaccharide-Based Conjugate Vaccines for Serotype C Moraxella catarrhalis. Infect. Immun. 75: 2974-2980 [Abstract] [Full Text]  
  • Liu, D.-F., McMichael, J. C., Baker, S. M. (2007). Moraxella catarrhalis Outer Membrane Protein CD Elicits Antibodies That Inhibit CD Binding to Human Mucin and Enhance Pulmonary Clearance of M. catarrhalis in a Mouse Model. Infect. Immun. 75: 2818-2825 [Abstract] [Full Text]  
  • Plamondon, P., Luke, N. R., Campagnari, A. A. (2007). Identification of a Novel Two-Partner Secretion Locus in Moraxella catarrhalis. Infect. Immun. 75: 2929-2936 [Abstract] [Full Text]  
  • Becker, P. D., Bertot, G. M., Souss, D., Ebensen, T., Guzman, C. A., Grinstein, S. (2007). Intranasal Vaccination with Recombinant Outer Membrane Protein CD and Adamantylamide Dipeptide as the Mucosal Adjuvant Enhances Pulmonary Clearance of Moraxella catarrhalis in an Experimental Murine Model. Infect. Immun. 75: 1778-1784 [Abstract] [Full Text]  
  • Wang, W., Pearson, M. M., Attia, A. S., Blick, R. J., Hansen, E. J. (2007). A UspA2H-Negative Variant of Moraxella catarrhalis Strain O46E Has a Deletion in a Homopolymeric Nucleotide Repeat Common to uspA2H Genes. Infect. Immun. 75: 2035-2045 [Abstract] [Full Text]  
  • Attia, A. S., Hansen, E. J. (2006). A Conserved Tetranucleotide Repeat Is Necessary for Wild-Type Expression of the Moraxella catarrhalis UspA2 Protein. J. Bacteriol. 188: 7840-7852 [Abstract] [Full Text]  
  • Attia, A. S., Ram, S., Rice, P. A., Hansen, E. J. (2006). Binding of Vitronectin by the Moraxella catarrhalis UspA2 Protein Interferes with Late Stages of the Complement Cascade. Infect. Immun. 74: 1597-1611 [Abstract] [Full Text]  
  • Nordstrom, T., Jendholm, J., Samuelsson, M., Forsgren, A., Riesbeck, K. (2006). The IgD-binding domain of the Moraxella IgD-binding protein MID (MID962-1200) activates human B cells in the presence of T cell cytokines. J. Leukoc. Biol. 79: 319-329 [Abstract] [Full Text]  
  • Edwards, K. J., Schwingel, J. M., Datta, A. K., Campagnari, A. A. (2005). Multiplex PCR Assay That Identifies the Major Lipooligosaccharide Serotype Expressed by Moraxella catarrhalis Clinical Isolates. J. Clin. Microbiol. 43: 6139-6143 [Abstract] [Full Text]  
  • Peng, D., Hong, W., Choudhury, B. P., Carlson, R. W., Gu, X.-X. (2005). Moraxella catarrhalis Bacterium without Endotoxin, a Potential Vaccine Candidate. Infect. Immun. 73: 7569-7577 [Abstract] [Full Text]  
  • Easton, D. M., Smith, A., Gallego, S. G., Foxwell, A. R., Cripps, A. W., Kyd, J. M. (2005). Characterization of a Novel Porin Protein from Moraxella catarrhalis and Identification of an Immunodominant Surface Loop. J. Bacteriol. 187: 6528-6535 [Abstract] [Full Text]  
  • Peng, D., Choudhury, B. P., Petralia, R. S., Carlson, R. W., Gu, X.-X. (2005). Roles of 3-Deoxy-D-manno-2-Octulosonic Acid Transferase from Moraxella catarrhalis in Lipooligosaccharide Biosynthesis and Virulence. Infect. Immun. 73: 4222-4230 [Abstract] [Full Text]  
  • Yu, S., Gu, X.-X. (2005). Synthesis and Characterization of Lipooligosaccharide-Based Conjugate Vaccines for Serotype B Moraxella catarrhalis. Infect. Immun. 73: 2790-2796 [Abstract] [Full Text]  
  • Edwards, K. J., Allen, S., Gibson, B. W., Campagnari, A. A. (2005). Characterization of a Cluster of Three Glycosyltransferase Enzymes Essential for Moraxella catarrhalis Lipooligosaccharide Assembly. J. Bacteriol. 187: 2939-2947 [Abstract] [Full Text]  
  • Attia, A. S., Lafontaine, E. R., Latimer, J. L., Aebi, C., Syrogiannopoulos, G. A., Hansen, E. J. (2005). The UspA2 Protein of Moraxella catarrhalis Is Directly Involved in the Expression of Serum Resistance. Infect. Immun. 73: 2400-2410 [Abstract] [Full Text]  
  • Furano, K., Luke, N. R., Howlett, A. J., Campagnari, A. A. (2005). Identification of a conserved Moraxella catarrhalis haemoglobin-utilization protein, MhuA. Microbiology 151: 1151-1158 [Abstract] [Full Text]  
  • Rosseau, S., Wiechmann, K., Moderer, S., Selhorst, J., Mayer, K., Krull, M., Hocke, A., Slevogt, H., Seeger, W., Suttorp, N., Seybold, J., Lohmeyer, J. (2005). Moraxella catarrhalis-Infected Alveolar Epithelium Induced Monocyte Recruitment and Oxidative Burst. Am. J. Respir. Cell Mol. Bio. 32: 157-166 [Abstract] [Full Text]  
  • Luke, N. R., Howlett, A. J., Shao, J., Campagnari, A. A. (2004). Expression of Type IV Pili by Moraxella catarrhalis Is Essential for Natural Competence and Is Affected by Iron Limitation. Infect. Immun. 72: 6262-6270 [Abstract] [Full Text]  
  • Sulikowska, A., Grzesiowski, P., Sadowy, E., Fiett, J., Hryniewicz, W. (2004). Characteristics of Streptococcus pneumoniae, Haemophilus influenzae, and Moraxella catarrhalis Isolated from the Nasopharynges of Asymptomatic Children and Molecular Analysis of S. pneumoniae and H. influenzae Strain Replacement in the Nasopharynx. J. Clin. Microbiol. 42: 3942-3949 [Abstract] [Full Text]  
  • Olivieri, I, Padula, A, Armignacco, L, Sabatella, V, Mancino, M (2004). Septic arthritis caused by Moraxella catarrhalis associated with infliximab treatment in a patient with undifferentiated spondarthritis. Ann Rheum Dis 63: 105-106 [Full Text]  
  • Luke, N. R., Allen, S., Gibson, B. W., Campagnari, A. A. (2003). Identification of a 3-Deoxy-D-manno-Octulosonic Acid Biosynthetic Operon in Moraxella catarrhalis and Analysis of a KdsA-Deficient Isogenic Mutant. Infect. Immun. 71: 6426-6434 [Abstract] [Full Text]  
  • Hays, J. P., Eadie, K., Verduin, C. M., Hazelzet, J., Verbrugh, H., van Belkum, A. (2003). Changes in genetic types and population dynamics of Moraxella catarrhalis in hospitalized children are not associated with an exacerbation of existing disease. J Med Microbiol 52: 815-820 [Abstract] [Full Text]  
  • Furano, K., Campagnari, A. A. (2003). Inactivation of the Moraxella catarrhalis 7169 Ferric Uptake Regulator Increases Susceptibility to the Bactericidal Activity of Normal Human Sera. Infect. Immun. 71: 1843-1848 [Abstract] [Full Text]  
  • Greiner, O., Day, P. J. R., Altwegg, M., Nadal, D. (2003). Quantitative Detection of Moraxella catarrhalis in Nasopharyngeal Secretions by Real-Time PCR. J. Clin. Microbiol. 41: 1386-1390 [Abstract] [Full Text]  
  • Vela, A. I., Collins, M. D., Latre, M. V., Mateos, A., Moreno, M. A., Hutson, R., Dominguez, L., Fernandez-Garayzabal, J. F. (2003). Psychrobacter pulmonis sp. nov., isolated from the lungs of lambs. Int. J. Syst. Evol. Microbiol. 53: 415-419 [Abstract] [Full Text]  
  • Bowers, L. C., Purcell, J. E., Plauche, G. B., Denoel, P. A., Lobet, Y., Philipp, M. T. (2002). Assessment of the Nasopharyngeal Bacterial Flora of Rhesus Macaques: Moraxella, Neisseria, Haemophilus, and Other Genera. J. Clin. Microbiol. 40: 4340-4342 [Abstract] [Full Text]  
  • Tan, L., Grewal, P. S. (2002). Endotoxin Activity of Moraxella osloensis against the Grey Garden Slug, Deroceras reticulatum. Appl. Environ. Microbiol. 68: 3943-3947 [Abstract] [Full Text]